Risk-prediction tools in prostate cancer: the challenge of tailoring.
作者信息
Morlacco Alessandro, Pan Jiahua, Karnes R Jeffrey
机构信息
Department of Urology, Mayo Clinic, Rochester, MN, USA.
Department of Urology, Renji Hospital, Shanghai, China.
出版信息
Asian J Androl. 2016 Nov-Dec;18(6):952. doi: 10.4103/1008-682X.179526.
Abstract
摘要
相似文献
1
Risk-prediction tools in prostate cancer: the challenge of tailoring.前列腺癌的风险预测工具：个性化的挑战。
Asian J Androl. 2016 Nov-Dec;18(6):952. doi: 10.4103/1008-682X.179526.
2
Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models.确定根治性前列腺切除术后癌症特异性死亡率的最具信息性预测工具：三种常用术前预测模型的比较分析。
Eur Urol. 2016 Jun;69(6):1038-43. doi: 10.1016/j.eururo.2015.07.051. Epub 2015 Aug 10.
3
Where we are with screening and risk prediction for prostate cancer in 2016.
BJU Int. 2016 Mar;117(3):381. doi: 10.1111/bju.13420.
4
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.澳大利亚前列腺癌患者三种风险评估工具的比较分析。
BJU Int. 2011 Nov;108 Suppl 2:51-6. doi: 10.1111/j.1464-410X.2011.10687.x.
5
Novel Definitions of Low-risk and High-risk Prostate Cancer: Implications for the European Randomized Study of Screening for Prostate Cancer Risk Assessment Tool.低风险和高风险前列腺癌的新定义：对欧洲前列腺癌筛查随机研究风险评估工具的影响。
Eur Urol. 2017 Jul;72(1):52-53. doi: 10.1016/j.eururo.2017.02.009. Epub 2017 Feb 17.
6
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.应用前列腺癌风险评估评分预测前列腺癌患者转移复发风险：来自 2937 例欧洲患者的研究结果。
BJU Int. 2012 Dec;110(11):1714-20. doi: 10.1111/j.1464-410X.2012.11147.x. Epub 2012 Apr 23.
7
Unorganized prostate-specific antigen-based screening for prostate cancer: more harm than benefit. When will we finally start to implement guidelines and risk assessment tools in clinical practice?基于无组织前列腺特异性抗原的前列腺癌筛查：弊大于利。我们最终何时才会开始在临床实践中实施指南和风险评估工具？
Eur Urol. 2015 Sep;68(3):363-4. doi: 10.1016/j.eururo.2015.02.036. Epub 2015 Mar 11.
8
Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer: Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk.低风险前列腺癌的转录组异质性：是时候从前列腺癌风险评估（CAPRA）转向临床基因组风险评估了。
Eur Urol. 2018 Oct;74(4):453-454. doi: 10.1016/j.eururo.2018.06.001. Epub 2018 Jun 12.
9
Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?分子标志物能否分层高分级前列腺上皮内瘤变的诊断价值？
Hum Pathol. 2011 May;42(5):702-9. doi: 10.1016/j.humpath.2010.09.006. Epub 2011 Jan 15.
10
Screening for prostate cancer.前列腺癌筛查
CA Cancer J Clin. 2009 Jul-Aug;59(4):264-73. doi: 10.3322/caac.20026. Epub 2009 Jun 29.
引用本文的文献
1
Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer.血清中原钙黏蛋白 8（PCDH8）启动子异常甲基化是低格里森评分前列腺癌的潜在预后标志物。
Med Sci Monit. 2017 Oct 13;23:4895-4900. doi: 10.12659/msm.904366.
本文引用的文献
1
The Huashan risk calculators performed better in prediction of prostate cancer in Chinese population: a training study followed by a validation study.华山风险计算器在预测中国人群前列腺癌方面表现更佳：一项先进行训练研究后进行验证研究的实验。
Asian J Androl. 2016 Nov-Dec;18(6):925-929. doi: 10.4103/1008-682X.181192.
2
The updated incidences and mortalities of major cancers in China, 2011.2011年中国主要癌症的最新发病率和死亡率。
Chin J Cancer. 2015 Sep 14;34(11):502-7. doi: 10.1186/s40880-015-0042-6.
3
Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009.1973年至2009年中国上海前列腺癌发病率和死亡率趋势
Prostate. 2015 Oct;75(14):1662-8. doi: 10.1002/pros.23046. Epub 2015 Jul 17.
4
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators.改善患者前列腺癌风险评估：从静态的、全球通用的风险计算器转向动态的、针对具体临床实践的风险计算器。
J Biomed Inform. 2015 Aug;56:87-93. doi: 10.1016/j.jbi.2015.05.001. Epub 2015 May 16.
5
Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.前列腺癌风险模型是否能提高 PSA 筛查的预测准确性？一项荟萃分析。
Ann Oncol. 2015 May;26(5):848-864. doi: 10.1093/annonc/mdu525. Epub 2014 Nov 17.
6
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort.在中国队列中对前列腺癌预防试验和欧洲前列腺癌筛查风险计算器随机研究的风险计算器进行外部验证。
Asian J Androl. 2012 Sep;14(5):738-44. doi: 10.1038/aja.2012.28. Epub 2012 May 7.
7
Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.评估前列腺癌风险：前列腺癌预防试验的结果
J Natl Cancer Inst. 2006 Apr 19;98(8):529-34. doi: 10.1093/jnci/djj131.
Zotero 插件